Many women greatly look forward to their pregnancy: that pregnancy glow, a slowly swelling belly, the knowledge that you are creating and sustaining a life, but sadly for a large proportion of women, the reality is quite different. Morning sickness is a huge struggle for a lot of women, often rendering whole chunks of days as a write-off. The Duchess of Cambridge, Kate Middleton was herself hospitalised earlier this year due to severe morning sickness.
All could soon be changing for the better, however, as the US Food and Drug Administration (FDA) have recently approved a new drug called Diclegis. A study carried out with 261 women between 7 and 14 weeks pregnant found that Diclegis reduced symptoms of nausea and vomiting significantly.
The recommended daily dosage for women new to the drug is 2 before bed, on an empty stomach. For severe morning sickness, doctors recommend taking one in the morning, one in the afternoon and then two prior to sleeping.
The FDA have also stated that Diclegis poses no risk to the foetus and causes minor side effects, such as drowsiness – for this reason, women are advised to avoid driving or operating machinery.
Diclegis has been put through rigorous testing and analyses before being approved after a morning sickness drug called Bendectin discontinued 30 years ago after fear that this drug could cause birth defects. Thankfully, this previous scare proved to be just that, a false-alarm.